New drug slows progression of Alzheimer's
A breakthrough in treating Alzheimer's disease is reported by pharmaceutical companies Eisai and Biogen, using a drug called lecanemab, which is designed to remove beta-amyloid proteins from the brain.
www.futuretimeline.net